Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

A cytokine-mediated link between innate immunity, inflammation, and cancer
Wan-Wan Lin, Michael Karin
Wan-Wan Lin, Michael Karin
Published May 1, 2007
Citation Information: J Clin Invest. 2007;117(5):1175-1183. https://doi.org/10.1172/JCI31537.
View: Text | PDF
Review Series Article has an altmetric score of 15

A cytokine-mediated link between innate immunity, inflammation, and cancer

  • Text
  • PDF
Abstract

It has been established that cancer can be promoted and/or exacerbated by inflammation and infections. Indeed, chronic inflammation orchestrates a tumor-supporting microenvironment that is an indispensable participant in the neoplastic process. The mechanisms that link infection, innate immunity, inflammation, and cancer are being unraveled at a fast pace. Important components in this linkage are the cytokines produced by activated innate immune cells that stimulate tumor growth and progression. In addition, soluble mediators produced by cancer cells recruit and activate inflammatory cells, which further stimulate tumor progression. However, inflammatory cells also produce cytokines that can limit tumor growth. Here we provide an overview of the current understanding of the role of inflammation-induced cytokines in tumor initiation, promotion, and progression.

Authors

Wan-Wan Lin, Michael Karin

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 Total
Citations: 10 31 43 52 69 41 43 42 53 47 53 41 43 42 44 46 54 34 3 791
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2011 (44)

Title and authors Publication Year
Tumor development in ulcerative colitis in mice depends on MyD88 signaling of colonic F4/80+ CD11bhigh Gr1low macrophages
Gabriela Schiechl, Bernhard Bauer, Ivan J Fuss, Sven Lang, Christian Moser, Petra Ruemmele, Stefan Rose-John, Markus F. Neurath, Edward Geissler, Hans J Schlitt, Warren Strober, Stefan Fichtner-Feigl
Journal of Clinical Investigation 2011
Transforming growth factor-β and the hallmarks of cancer
M Tian, JR Neil, WP Schiemann
Cellular Signalling 2011
An immunologic portrait of cancer
ML Ascierto, VD Giorgi, Q Liu, D Bedognetti, TL Spivey, D Murtas, L Uccellini, BD Ayotte, DF Stroncek, L Chouchane, MH Manjili, E Wang, FM Marincola
Journal of Translational Medicine 2011
Acquisition of Genetic Aberrations by Activation-Induced Cytidine Deaminase (AID) during Inflammation-Associated Carcinogenesis
A Takai, H Marusawa, T Chiba
Cancers 2011
IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals
JH Oh, MC Cho, JH Kim, SY Lee, HJ Kim, ES Park, JO Ban, JW Kang, DH Lee, JH Shim, SB Han, DC Moon, YH Park, DY Yu, JM Kim, SH Kim, DY Yoon, JT Hong
Oncogene 2011
Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis
M Labelle, S Begum, RO Hynes
Cancer Cell 2011
Role of TLR2-dependent inflammation in metastatic progression
S Kim, M Karin
Annals of the New York Academy of Sciences 2011
Inflammatory alterations of the extracellular matrix in the tumor microenvironment
J Iijima, K Konno, N Itano
Cancers 2011
Suppressor of cytokine signalling protein SOCS3 expression is increased at sites of acute and chronic inflammation
GE White, A Cotterill, MR Addley, EJ Soilleux, DR Greaves
Journal Of Molecular Histology 2011
The E3 ligase Itch and deubiquitinase Cyld co-operatively regulate Tak1 and inflammation
N Ahmed, M Zeng, I Sinha, L Polin, WZ Wei, C Rathinam, R Flavell, R Massoumi, K Venuprasad
Nature Immunology 2011
Minireview: Nuclear Receptors as Modulators of the Tumor Microenvironment
MH Sherman, M Downes, RM Evans
Cancer prevention research (Philadelphia, Pa.) 2011
T Cells and Adoptive Immunotherapy: Recent Developments and Future Prospects in Gastrointestinal Oncology
A Amedei, E Niccolai, MM D'Elios
Clinical and Developmental Immunology 2011
Previous lung diseases and lung cancer risk: a systematic review and meta-analysis
DR Brenner, JR McLaughlin, RJ Hung
PloS one 2011
Polymorphisms of interleukin-10 promoter are not associated with prognosis of advanced gastric cancer
J Liu, B Song, JL Wang, ZJ Li, WH Li, ZH Wang
World journal of gastroenterology : WJG 2011
Carcinoma-derived interleukin-8 disorients dendritic cell migration without impairing T-cell stimulation
C Alfaro, N Suárez, I Martínez-Forero, A Palazón, A Rouzaut, S Solano, E Feijoo, A Gúrpide, E Bolaños, L Erro, J Dubrot, S Hervás-Stubbs, A Gonzalez, JL Perez-Gracia, I Melero
PloS one 2011
Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer
OA Haabeth, KB Lorvik, C Hammarström, IM Donaldson, G Haraldsen, B Bogen, A Corthay
Nature Communications 2011
An NF-κB p65-cIAP2 link is necessary for mediating resistance to TNF-α induced cell death in gliomas
X Zhao, T Laver, SW Hong, GB Twitty, A DeVos, M DeVos, EN Benveniste, SE Nozell
Journal of Neuro-Oncology 2011
Increased Levels of Circulating Interleukin 6, Interleukin 8, C-Reactive Protein, and Risk of Lung Cancer
SR Pine, LE Mechanic, L Enewold, AK Chaturvedi, HA Katki, YL Zheng, ED Bowman, EA Engels, NE Caporaso, CC Harris
JNCI Journal of the National Cancer Institute 2011
Inflammatory signaling compromises cell responses to interferon alpha
WC Huangfu, J Qian, C Liu, J Liu, AE Lokshin, DP Baker, H Rui, SY Fuchs
Oncogene 2011
Targeting surface nucleolin with multivalent HB-19 and related Nucant pseudopeptides results in distinct inhibitory mechanisms depending on the malignant tumor cell type
B Krust, DE Khoury, I Nondier, C Soundaramourty, AG Hovanessian
BMC Cancer 2011
Protein Signaling Networks from Single Cell Fluctuations and Information Theory Profiling
YS Shin, F Remacle, R Fan, K Hwang, W Wei, H Ahmad, RD Levine, JR Heath
Biophysical Journal 2011
BCG response prediction with cytokine gene variants and bladder cancer: where we are?
DK Ahirwar, PK Manchanda, RD Mittal, HK Bid
Journal of Cancer Research and Clinical Oncology 2011
GLOBAL GENE EXPRESSION CHANGES IN HUMAN UROTHELIAL CELLS EXPOSED TO LOW-LEVEL MONOMETHYLARSONOUS ACID
M Medeiros, X Zheng, P Novak, SM Wnek, V Chyan, C Escudero-Lourdes, AJ Gandolfi
Toxicology 2011
IAPs: Guardians of RIPK1
M Darding, P Meier
Cell Death and Differentiation 2011
Computational Modeling of Interactions between Multiple Myeloma and the Bone Microenvironment
Y Wang, P Pivonka, PR Buenzli, DW Smith, CR Dunstan
PloS one 2011
The Role of Chalcones in Suppression of NF-κB-Mediated Inflammation and Cancer
VR Yadav, S Prasad, B Sung, BB Aggarwal
International Immunopharmacology 2011
Mannose Receptor (MR) Engagement by Mesothelin GPI Anchor Polarizes Tumor-Associated Macrophages and Is Blocked by Anti-MR Human Recombinant Antibody
D Dangaj, KL Abbott, A Mookerjee, A Zhao, PS Kirby, R Sandaltzopoulos, DJ Powell, A Lamazière, DL Siegel, C Wolf, N Scholler
PloS one 2011
Do Interleukin Polymorphisms Play a Role in the Prevention of Colorectal Adenoma Recurrence by Dietary Flavonols?
G Bobe, G Murphy, PS Albert, LB Sansbury, MR Young, E Lanza, A Schatzkin, NH Colburn, AJ Cross
European Journal of Cancer Prevention 2011
Regulation of prostate cancer immunity-related genes in PC3 prostate cancer cells by ETS-1
Z Shaikhibrahim, A Lindstrot, R Buettner, N Wernert
Oncology Letters 2011
Glucocorticoid-independent Repression of Tumor Necrosis Factor (TNF) α-stimulated Interleukin (IL)-6 Expression by the Glucocorticoid Receptor
NJ Verhoog, AD Toit, C Avenant, JP Hapgood
The Journal of biological chemistry 2011
Wounding mobilizes hair follicle stem cells to form tumors
SY Wong, JF Reiter
Proceedings of the National Academy of Sciences 2011
The polymorphisms of IL-4, IL-4R and IL-13 genes and bladder cancer risk in a Chinese population: a case-control study
H Chu, L Ma, M Wang, D Shi, C Qin, L Yuan, C Yin, Z Zhang
Molecular Biology Reports 2011
A critical role for macrophages in promotion of urethane-induced lung carcinogenesis
R Zaynagetdinov, TP Sherrill, VV Polosukhin, W Han, JA Ausborn, AG McLoed, FB McMahon, LA Gleaves, AL Degryse, GT Stathopoulos, FE Yull, TS Blackwell
Journal of immunology (Baltimore, Md. : 1950) 2011
Chronic ethanol feeding accelerates hepatocellular carcinoma progression in a sex-dependent manner in a mouse model of hepatocarcinogenesis
E Brandon-Warner, TL Walling, LW Schrum, IH McKillop
Alcoholism, clinical and experimental research 2011
Intra-individual variability over time in serum cytokine levels among participants in the prostate, lung, colorectal, and ovarian cancer screening Trial
JN Hofmann, K Yu, RK Bagni, Q Lan, N Rothman, MP Purdue
Cytokine 2011
Effect of Low-Fat Diets on Plasma Levels of NF-κB–Regulated Inflammatory Cytokines and Angiogenic Factors in Men with Prostate Cancer
JV Heymach, TJ Shackleford, HT Tran, SY Yoo, KA Do, M Wergin, P Saintigny, RT Vollmer, TJ Polascik, DC Snyder, MT Ruffin, S Yan, M Dewhirst, AB Kunnumakkara, BB Aggarwal, W Demark-Wahnefried
Cancer prevention research (Philadelphia, Pa.) 2011
NADPH Oxidase: a Target for the Modulation of the Excessive Oxidase Damage Induced by Overtraining in Rat Neutrophils
Dong J, Chen P, Wang R, Yu D, Zhang Y, Xiao W
International journal of biological sciences 2011
Molecular damage in cancer: an argument for mTOR-driven aging
Blagosklonny MV
Aging 2011
Inflammation and colorectal cancer: does aspirin affect the interaction between cancer and immune cells?
Bergman M, Djaldetti M, Salman H, Bessler H
Inflammation 2011
Cytokines, inflammation and colon cancer.
Klampfer L
Current cancer drug targets 2011
Inhibition of TGF-β signaling, vasculogenic mimicry and proinflammatory gene expression by isoxanthohumol.
Serwe A, Rudolph K, Anke T, Erkel G
Investigational New Drugs 2011
Dual Roles of Immune Cells and Their Factors in Cancer Development and Progression
Zamarron BF, Chen W
International journal of biological sciences 2011
(+)-Episesamin exerts anti-neoplastic effects in human hepatocellular carcinoma cell lines via suppression of nuclear factor-kappa B and inhibition of MMP-9.
Freise C, Trowitzsch-Kienast W, Ruehl M, Erben U, Seehofer D, Kim KY, Zeitz M, Somasundaram R
Investigational New Drugs 2011
SCF and TLR4 ligand cooperate to augment the tumor-promoting potential of mast cells
Wei JJ, Song CW, Sun LC, Yuan Y, Li D, Yan B, Liao SJ, Zhu JH, Wang Q, Zhang GM, Feng ZH
Cancer Immunology, Immunotherapy 2011

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 23 patents
Referenced in 1 Wikipedia pages
1245 readers on Mendeley
7 readers on CiteULike
See more details